Dalfopristinum

Dalfopristinum Uses, Dosage, Side Effects, Food Interaction and all others data.

Dalfopristinum is a combination of two antibiotics (Dalfopristinum and quinupristin) used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium. It is not effective against Enterococcus faecalis infections. Dalfopristinum inhibits the early phase of protein synthesis in the bacterial ribosome and quinupristin inhibits the late phase of protein synthesis.

Dalfopristinum is a streptogramin antibiotic, derived from pristinamycin IIA.

Table Of contents

• Dalfopristinum
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Dalfopristinum
Generic	Dalfopristin
Dalfopristin Other Names	Dalfopristin, Dalfopristina, Dalfopristine, Dalfopristinum
Type
Formula	C34H50N4O9S
Weight	Average: 690.85 Monoisotopic: 690.32985038
Protein binding	Moderate
Groups	Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Dalfopristinum is an antibiotic used with quinupristin to treat severe or life-threatening infections of vancomycin-resistant Enterococcus faecium (VREF), and skin infections caused by methicillin susceptible staphylococcus aureus or streptococcus pyogenes.

For the treatment of bacterial infections (usually in combination with quinupristin).

Dalfopristinum is also used to associated treatment for these conditions: Bacterial Infections, Infections caused by penicillinase-producing staphylococci, Complicated Skin and subcutaneous tissue bacterial infection

How Dalfopristinum works

The site of action of dalfopristin is the bacterial ribosome. Dalfopristinum has been shown to inhibit the early phase of protein synthesis.

Food Interaction

No interactions found.

Half Life

The elimination half-life is approximately 0.70 hours.

Innovators Monograph

You find simplified version here Dalfopristinum